Basiliximab — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

2 Recruiting

1 Completed trials

4 Sponsors

4 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 3

Indications tested

4 total

MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZATION OF IMMUNOLOGICAL RISK BASED ON SELECTIVE BIOMARKERS (HLA EPLE… Pending

2025-520884-42-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Reduced Immunosuppression for Older Adult Kidney Transplant Recipients: the RELEASE study. Recruiting

2025-520535-16-00 Phase IV 1 country Consorci Mar Parc De Salut De Barcelona
INduction in Sensitized kidney Transplant recipients without pre-Existing donor-specific AntiboDies: a randomized multicentre trial between … Recruiting

2022-502007-30-00 Phase III 1 country Centre Hospitalier Regional Universitaire De Tours
OPTIMIZE Ended

2024-516509-22-00 Phase IV 2 countries Universitair Medisch Centrum Groningen

Showing 1–4 of 4 trials